The low dose dexamethasone suppression test: Effect of time of administration and dose

被引:6
作者
Barton, C
March, S
Wittert, GA [1 ]
机构
[1] Univ Adelaide, Dept Med, Royal Adelaide Hosp, Adelaide, SA 5000, Australia
[2] Univ Adelaide, Dept Psychiat, Royal Adelaide Hosp, Adelaide, SA, Australia
关键词
dexamethasone suppression test; time; dose; cortisol;
D O I
10.1007/BF03344008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The dexamethasone suppression test (DST) is used to determine the sensitivity of the hypothalamic-pituitary-ad renal axis (HPA-axis) to negative feedback. Dexamethasone is usually administered at 23:00 h or at midnight but this is often not convenient. The aim of this study was to determine whether the administration of dexamethasone at 2 1:00 h as compared to 23:00 h would alter the degree to which 08:00 h plasma cortisol was suppressed the following morning. Three healthy males (mean+/-SE: 32+/-7 yr) and 3 healthy females (mean SE: 35+/-7 yr) took part in the study. Each subject was orally administered I of 3 doses of dexamethasone (0.25 mg, 0.5 mg, or 1.0 mg) on 3 separate occasions in random order at least a week apart. Each dose of dexamethasone was taken at either 2 1:00 h or 23:00 h so that each subject underwent 6 tests. The differences in cortisol suppression between times and doses of dexamethasone were assessed using Analysis of Variance. Plasma cortisol was suppressed less in response to 0.25 mg dexamethasone at both 2 1:00 h and 23:00 h as compared with doses of dexamethasone of 0.5 mg or 1.0 mg (p=0.004). Suppression of plasma cortisol in response to each dose of clexamethasone was similar regardless of the timing of clexamethasone administration (p=0.5). We conclude that in healthy subjects 0.25 mg dexamethasone suppresses plasma cortisol less than either 0.5 mg or 1.0 mg and that 0.5 mg dexamethasone suppresses plasma cortisol to a similar extent as 1.0 mg dexamethasone. Moreover, changing the administration time of dexamethasone from 23:00 h to 2 1:00 h does not effect the degree to which cortisol is suppressed in healthy subjects. (C) 2002, Editrice Kurtis.
引用
收藏
页码:RC10 / RC12
页数:3
相关论文
共 6 条
[1]   Effectiveness versus efficacy: The limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome [J].
Aron, DC ;
Raff, H ;
Findling, JW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) :1780-1785
[2]   CUSHINGS-SYNDROME - REVIEW OF DIAGNOSTIC-TESTS [J].
CRAPO, L .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (09) :955-977
[3]   THE DEXAMETHASONE SUPPRESSION TEST AND THYROTROPIN-RELEASING-HORMONE STIMULATION TEST IN POSTTRAUMATIC-STRESS-DISORDER [J].
KOSTEN, TR ;
WAHBY, V ;
GILLER, E ;
MASON, J .
BIOLOGICAL PSYCHIATRY, 1990, 28 (08) :657-664
[4]  
RUPPRECHT R, 1988, J NEURAL TRANSM, V75, P167
[5]  
SACHAR EJ, 1973, ARCH GEN PSYCHIAT, V28, P19
[6]   Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome - Recommendations for a protocol for biochemistry laboratories [J].
Wood, PJ ;
Barth, JH ;
Freedman, DB ;
Perry, L ;
Sheridan, B .
ANNALS OF CLINICAL BIOCHEMISTRY, 1997, 34 :222-229